Competition record
Reckitt
Deep profile · 0 linked library matters
Reckitt sells Lysol, Dettol, Finish, Durex, Mucinex, and Enfamil infant formula through Mead Johnson. Procter & Gamble and Colgate contest the cleaning aisle, and Abbott and Danone contest formula, including hospital contracts.
Overview
Reckitt is based in Slough. Lysol and Dettol dominate disinfectant conversations in the United States and many other countries, Finish competes in dishwash, and Durex and Mucinex are health brands sold through pharmacies and mass retail.
Mead Johnson's Enfamil is one of the two main infant-formula brands in the United States alongside Abbott's Similac, with Danone and Nestle stronger in other countries. Hospitals and public nutrition programs that specify a formula send parents home on that brand, which is why those contracts are the competitive prize.
Reckitt has described Mead Johnson as a business it could separate. A sale would move Enfamil's hospital and retail relationships to a new owner, which is the transaction to watch, while Lysol shelf space against private label is the everyday retail contest.
Competition footprint
Hospital and public-program formula awards steer infants onto Enfamil or Similac.
Disinfectant facings for Lysol and Dettol are a mass-retail contest with private label and P&G.
Pharmacy brands such as Mucinex depend on recommendation and on cold-aisle space.
Consumer & business angle
Parents discharged from a hospital on Enfamil repurchase that brand if the contract made it the default.
Households buying Lysol are choosing a branded disinfectant against the store's own bottle.
What to watch
- Whether Mead Johnson and Enfamil stay inside Reckitt or move to a new owner.
- Hospital formula contract renewals against Abbott, and Lysol share versus private label.
Markets
household disinfectants · infant formula · consumer health
Also known as: reckitt, lysol, enfamil, mead johnson, durex
Conduct themes
Linked cases in the library
No linked matters in the current library yet. The narrative above is still a market-power primer — check primary sources for live disputes.